arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Cellectar Biosciences, Inc.

CLRB

$2.50 ▲ +0.02 (+0.81%) at close

24 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Cellectar Biosciences, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $6.5M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -212.6% ↗

FCF / Share $-8.87 ↗

Trailing P/E —

Price / Book 1.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 6, 2026.

24-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-21.79M

↑ +51.1% —

FCF / Share Free cash flow per share

$-8.87

↑ +77.3% —

Long-Term Debt Long-term obligations

$330.22K

↓ -26.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Nov 6, 2002 10-K ↗
EPS Growth YoY (%)	77.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	65.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	13.6% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	6.9% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	-472.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	51.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-4.2% Weak ↑ Weak Improving Year-over-year change in net income	-49.5% Weak ↓ Weak Declining Year-over-year change in net income	-18.6% Weak ↑ Weak Improving Year-over-year change in net income	-59.8% Weak ↓ Weak Declining Year-over-year change in net income	-7.1% Weak ↑ Weak Improving Year-over-year change in net income	-6.4% Weak ↑ Weak Improving Year-over-year change in net income	2.4% Caution ↑ Caution Improving Year-over-year change in net income	-119.4% Weak ↓ Weak Declining Year-over-year change in net income	-12.5% Weak ↓ Weak Declining Year-over-year change in net income	31.8% Excellent ↑ Excellent Improving Year-over-year change in net income	84.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-26.8% Weak ↑ Weak Improving Year-over-year change in net income	-441.7% Weak ↓ Weak Declining Year-over-year change in net income	-63.0% Weak ↓ Weak Declining Year-over-year change in net income	26.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-2.1% Weak ↑ Weak Improving Year-over-year change in net income	-19.7% Weak ↑ Weak Improving Year-over-year change in net income	-428.3% Weak ↓ Weak Declining Year-over-year change in net income	-100.0% Weak ↓ Weak Declining Year-over-year change in net income	-40.6% Weak Weak Year-over-year change in net income	-15.9% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	77.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	52.6% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	24.6% Good ↑ Good Improving Year-over-year change in free cash flow	11.8% Fair Fair Year-over-year change in free cash flow	-479.1% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Nov 6, 2002 10-K ↗
Effective Tax Rate (%) (%)	—	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.06x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.35x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Nov 6, 2002 10-K ↗
Return on Invested Capital (%)	-212.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-362.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	256.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-185.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-57.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-123.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-79.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-99.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-55.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-349.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-109.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1926.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-298.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-58.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-2476.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	-153.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-203.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-322.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-133.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-64.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-115.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-88.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-105.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-61.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-115.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-73.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-769.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-348.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-66.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-87.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-255.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1802%)	—	282.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1781%)	-184.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1330%)	-73.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-587%)	-27.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-284%)	-155.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1137%)	-99.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-766%)	-126.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-941%)	-45.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-404%)	—	-120.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-901%)	—	—	-78.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-623%)	—	-150.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1105%)	-61.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-512%)	-201.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1443%)	-14.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-198%)	-120.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-903%)	—	-76.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-607%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Nov 6, 2002 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	0.20x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-67%)	0.07x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-89%)	0.26x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-56%)	0.04x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	-9653.00x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-16112.07x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-37365.30x Weak Weak Operating income divided by interest expense Optimal: > 5x	-2172.86x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-13.20M	$-23.29M	$-9.56M	$-19.87M	$-35.70M	$-57.17M	$-10.61M	$-13.26M	$-10.01M	$-11.44M	$-3.53M	$-8.97M	$-1.97M	$-4.23M	$-5.51M	$-673.74K	$-980.12K	—	—	—	—	—	—	$0.00
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	-0.04x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.05x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.01x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.01x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Nov 6, 2002 10-K ↗
Basic EPS, GAAP (USD)	$-8.35	$-36.52	$-106.06	$-122.73	$-131.82	$-23.03	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-8.87	$-39.06	$-82.42	$-109.30	$-123.96	$-21.41	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$2.01	$9.31	$-22.14	$50.07	$163.89	$36.54	$29.25	$84.91	$195.60	$39.57	$58.26	$26.84	$0.90	$6.63	$7.78	$0.32	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$2.01	$9.31	$-22.14	$50.07	$163.89	$36.54	$29.25	$84.91	$165.12	$34.68	$-0.91	$20.12	$0.01	$5.54	$6.41	$0.32	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	2.61M	1.22M	403,312	232,837	183,202	653,818	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Nov 6, 2002 10-K ↗
Working Capital (USD)	$9.29M	$14.86M	$-14.91M	$15.00M	$32.58M	$54.38M	$8.62M	$12.33M	$8.36M	$10.56M	$-1.52M	$3.47M	$-1.76M	$4.40M	$5.31M	$374.96K	—	—	—	—	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	$330.22K	$450.00K	$450.00K	$450.00K	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$8.54M	$14.29M	$-15.16M	$15.51M	$33.05M	$54.79M	$9.06M	$13.26M	$10.75M	$13.54M	$1.65M	$6.70M	$1.70M	$10.16M	$9.48M	$133.76K	$4.13M	$9.84M	$2.53M	$6.55M	$400.21K	$46.17K	$388.94K	$0.00

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Nov 6, 2002 10-K ↗
Depreciation Expense (USD)	$213.60K	$291.65K	$192.38K	$148.44K	$149.91K	—	$132.80K	$82.27K	$1.55M	$356.67K	$362.50K	$367.20K	$3.34M	$2.91M	$584.84K	$580.11K	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-21.79M	$-44.58M	$-42.77M	$-28.60M	$-24.12M	$-15.09M	$-14.09M	$-13.24M	$-13.56M	$-6.18M	$-5.50M	$-8.05M	$-51.06M	$-40.28M	$-7.44M	$-4.56M	$-6.22M	$-6.09M	$-5.09M	$-963.44K	$-481.84K	$-342.76K	$-295.79K	—
Operating Cash Flow (USD)	$-23.12M	$-47.58M	$-32.38M	$-25.22M	$-22.57M	$-13.93M	$-11.69M	$-11.44M	$-11.02M	$-8.28M	—	—	—	$-31.72M	$-5.97M	$-3.38M	—	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 24 years · 74 quarters

Cellectar Biosciences, Inc.

Analytical Summary

24-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CLRB with peers